(June 14, 2021, 1:29 PM EDT) -- ALEXANDRIA, Va. — In a June 11 petition for inter partes review (IPR), Johnson & Johnson Surgical Vision Inc. (J&J) asserts that 11 claims of a patented “Phodisruptive Laser Treatment of the Crystalline Lens” would have been obvious to a person of skill in the art and should thus be canceled....